Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization

B.A. Mooso, R.L. Vinall, C.G. Tepper, R.M. Savoy, J.P. Cheung, S. Singh, S. Siddiqui, Y. Wang, R.G. Bedolla, A. Martinez, M. Mudryj, H.-J. Kung, R.W. DeVere White, P.M. Ghosh

研究成果: 雜誌貢獻文章

19 引文 斯高帕斯(Scopus)

摘要

As prostate cancer (CaP) is regulated by androgen receptor (AR) activity, metastatic CaP is treated with androgen deprivation therapy (ADT). Despite initial response, patients on ADT eventually progress to castration-resistant CaP (CRPC), which is currently incurable. We previously showed that cleavage of the 280 kDa structural protein Filamin A (FlnA) to a 90 kDa fragment, and nuclear localization of the cleaved product, sensitized CRPC cells to ADT. Hence, treatment promoting FlnA nuclear localization would enhance androgen responsiveness. Here, we show that FlnA nuclear localization induced apoptosis in CRPC cells during ADT, identifying it as a treatment tool in advanced CaP. Significantly, the natural product genistein combined polysaccharide (GCP) had a similar effect. Investigation of the mechanism of GCP-induced apoptosis showed that GCP induced FlnA cleavage and nuclear localization and that apoptosis resulting from GCP treatment was mediated by FlnA nuclear localization. Two main components of GCP are genistein and daidzein: the ability of GCP to induce G2 arrest was due to genistein whereas sensitivity to ADT stemmed from daidzein; hence, both were needed to mediate GCP's effects. FlnA cleavage is regulated by its phosphorylation; we show that ADT enhanced FlnA phosphorylation, which prevented its cleavage, whereas GCP inhibited FlnA phosphorylation, thereby sensitizing CaP cells to ADT. In a mouse model of CaP recurrence, GCP, but not vehicle, impeded relapse following castration, indicating that GCP, when administered with ADT, interrupted the development of CRPC. These results demonstrate the efficacy of GCP in promoting FlnA nuclear localization and enhancing androgen responsiveness in CaP. © 2012 Society for Endocrinology.
原文英語
頁(從 - 到)759-777
頁數19
期刊Endocrine-Related Cancer
19
發行號6
DOIs
出版狀態已發佈 - 十二月 2012
對外發佈Yes

    指紋

引用此

Mooso, B. A., Vinall, R. L., Tepper, C. G., Savoy, R. M., Cheung, J. P., Singh, S., Siddiqui, S., Wang, Y., Bedolla, R. G., Martinez, A., Mudryj, M., Kung, H-J., DeVere White, R. W., & Ghosh, P. M. (2012). Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocrine-Related Cancer, 19(6), 759-777. https://doi.org/10.1530/ERC-12-0171